Clinical snapshot — for veterinary teams
- Active ingredient / class: polysulfated glycosaminoglycan (PSGAG); FDA-approved disease-modifying osteoarthritis drug (DMOAD) for dogs (off-label cats)
- What’s distinctive: it’s an injectable series — 2 mg/lb IM, twice weekly for up to 4 weeks (max 8 injections) — repeated over the dog’s life when signs recur
- Mechanism: inhibits cartilage-degrading enzymes, reduces inflammation, and boosts joint-fluid lubrication — it slows OA progression, beyond what oral supplements do; not a steroid
- Onset: accumulates in the joint within ~2 hours, but benefit may take up to 4 weeks (often after 3–4 doses)
- Counsel clients on: generally well tolerated; transient injection-site soreness; don’t double doses
- Caution: related to heparin — bleeding/clotting concerns; caution with NSAIDs and in bleeding disorders or renal/hepatic impairment
Plain answer for owners who landed here: Adequan is different from a pill or chew — it’s an injection that actually helps slow arthritis, not just ease symptoms. The standard plan is two injections a week for four weeks (eight total), sometimes given at home (your vet will show you how) or at the clinic. It can take a few weeks — often after the third or fourth dose — to see your dog moving better, so it’s important to complete the whole series rather than stopping early. It’s well tolerated and isn’t a steroid. The course can be repeated later when stiffness returns.
What it’s used for — and why follow-up matters
Adequan stands apart from oral joint products: it’s an FDA-approved disease-modifying injection that slows cartilage breakdown. But that strength comes with a follow-up challenge unlike any oral medication — it’s an eight-injection series on a twice-weekly schedule, and the whole benefit depends on completing it. Whether the owner gives the IM injections at home or brings the dog in, missed doses and skipped appointments are the dominant failure mode. Layered on that: the benefit takes up to 4 weeks (so owners may doubt it early), and the course needs repeating when signs recur. Adherence to the schedule is the entire game — which is exactly what structured follow-up protects.
The adverse-event and monitoring profile
Per the FDA-approved labeling and veterinary references, Adequan is generally well tolerated and is not a steroid, so it lacks steroid-associated systemic effects; transient injection-site pain or swelling is the most common issue. Because PSGAG is related to heparin (an anticoagulant), bleeding/clotting concerns exist — so it’s used with caution alongside NSAIDs and in patients with bleeding disorders or renal/hepatic impairment. The protocol is 2 mg/lb IM twice weekly for up to 4 weeks (max 8 injections), not to be exceeded, repeated over the dog’s lifetime as signs recur; doses shouldn’t be doubled, and the vial has handling/expiry rules. Clinical improvement is often seen after 3–4 doses but may take the full 4 weeks. (Sources: Adequan Canine via PetMD; Polysulfated glycosaminoglycan — VCA Animal Hospitals; Adequan Canine labeling via DailyMed.)
The follow-up window that matters
The 4-week loading series is the critical window — eight injections that must actually happen on schedule. Then ongoing: tracking the mobility response (and not abandoning before week 4), and recognizing when to repeat the course as arthritis signs return.
What to ask clients at follow-up
A schedule-adherence and response check:
- Are you on track with the twice-weekly injections — any missed doses or skipped appointments?
- (If home injections) Are you comfortable with the IM technique and the schedule?
- Is your dog moving better yet? (remember it can take up to 4 weeks / 3–4 doses)
- Any injection-site soreness — and is your dog on any NSAID we should be mindful of?
The schedule question is decisive — an incomplete series undercuts the whole benefit.
Where compliance breaks down
The signature failure is an incomplete injection series — missed home doses or no-show clinic appointments — followed by abandoning before the ~4-week onset, and not returning to repeat the course when signs recur. All are scheduling/follow-up gaps, and all are exactly what a proactive reminder system fixes.
Standardizing this follow-up without adding staff time
This is a strong, somewhat unique fit for Nidana Loop. For an Adequan patient, Loop calls or texts to keep the eight-injection schedule on track (reminding before each dose, prompting rebooking of any missed clinic injection, and supporting home-injection technique), set the up-to-4-week onset expectation so owners don’t quit early, track the mobility response, and flag injection-site reactions — returning it as a structured note and surfacing missed doses or concerns to a vet. An injectable series gets the adherence scaffolding it needs, with no staff calls.
See Loop handle medication follow-up
Loop runs your injection-series reminders, onset-expectation reinforcement, and response check automatically — returning structured outcomes to the clinic. Book a 20-minute demo → · See how Loop works →
For pet owners
How is Adequan given? As an injection into the muscle — twice a week for four weeks (eight total), at home or at the clinic.
How soon will it work? Often after the third or fourth dose, but it can take the full four weeks — finish the whole series before judging.
Is it a steroid? No — it’s a cartilage-supporting drug that slows arthritis, without steroid side effects.
Can we do it again later? Yes — the course is repeated over your dog’s life when stiffness returns.
This article is general information, not veterinary advice. Owners should consult their veterinarian and follow the product’s FDA-approved label.
Sources: Adequan Canine via PetMD; Polysulfated glycosaminoglycan — VCA Animal Hospitals; Adequan Canine labeling via DailyMed.